BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Coagulation
,
Obesity
,
Lymphocyte
,
Neocentromeres
,
Aspirin
,
rs4950928
,
EGFR
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
C, -73
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Association of REarranged during Transfection (RET) c.73 + 9277T > C and c.135G > a Polymorphisms wi…
Interpenetrating three-dimensional diamondoid lattices and antiferromagnetic ordering (T(c) = 73 K) …
c-Jun N-terminal kinase (JNK)-phospho-c-JUN (ser63/73) pathway is essential for FOXP3 nuclear transl…
COX-2 contributes to P-glycoprotein-mediated multidrug resistance via phosphorylation of c-Jun at Se…
Applying a multi-criteria decision-making approach to identify key satisfaction gaps in hospital nur…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Model Towards Elimination of Hepatitis C Infection in Egypt: Feasibility and Effectiveness in 73 Vil…
Study of the Safety and Local Tolerability of Intranasal Gel Formulations of XF-73
OLE of Phase 2b/3 Study ANAVEX2-73-AD-004
Study of the Nasal Decolonisation of Staphylococcus Aureus (SA) and the Safety and Tolerability of X…
OLE Study for Patients With Parkinson's Disease With Dementia Enrolled in Study ANAVEX2-73-PDD-001
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ